Supplementary Tables 1 - 4 from JAK2 Expression Is Associated with Tumor-Infiltrating Lymphocytes and Improved Breast Cancer Outcomes: Implications for Evaluating JAK2 Inhibitors
PDF file - 53K, Supplementary Table S1. Taqman Assays. Supplementary Table S2. Characteristics of Patients by Recurrence Status. Supplementary Table S3. Case-Control Study of JAK2 mRNA Levels and Distant Breast Cancer Recurrence. Supplementary Table S4. JAK2 mRNA vs Protein Levels in Primary Breast Tumors.